Cancer Therapy-Related Cardiac Dysfunction: An Overview for the Clinician

Irving E Perez; Sara Taveras Alam; Gabriel A Hernandez; Rhea Sancassani

doi:10.1177/1179546819866445

Clinical Medicine Insights: Cardiology (Jul 2019)

Cancer Therapy-Related Cardiac Dysfunction: An Overview for the Clinician

Irving E Perez,
Sara Taveras Alam,
Gabriel A Hernandez,
Rhea Sancassani

Affiliations

Irving E Perez: Department of Cardiovascular Disease, Jackson Memorial Hospital, University of Miami Hospital, Miami, FL, USA
Sara Taveras Alam: Section of Hematology-Oncology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA
Gabriel A Hernandez: Department of Cardiovascular Disease, Jackson Memorial Hospital, University of Miami Hospital, Miami, FL, USA
Rhea Sancassani: Department of Cardiovascular Disease, Jackson Memorial Hospital, University of Miami Hospital, Miami, FL, USA

DOI: https://doi.org/10.1177/1179546819866445
Journal volume & issue: Vol. 13

Abstract

Read online

Cancer therapy-related cardiac dysfunction (CTRCD) is one of the most feared and undesirable side effects of chemotherapy, occurring in approximately 10% of the patients. It can be classified as direct (dose-dependent vs dose-independent) or indirect, either case being potentially permanent or reversible. Risk assessment, recognition, and prevention of CTRCD are crucial.

Published in Clinical Medicine Insights: Cardiology

ISSN: 1179-5468 (Online)
Publisher: SAGE Publishing
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system
Website: https://journals.sagepub.com/home/cic

About the journal